*By Carlo Versano*
Shares of the newly-public Chinese electric car company NIO surged for a second straight day Wednesday ー even amid a broader market slump ー on the news that Tesla's largest outside investor is taking a stake.
NIO ($NIO) was up as much as 5 percent on Wednesday morning, following an SEC [disclosure](https://www.sec.gov/Archives/edgar/data/1088875/000108887518000054/NIOInc30092018.txt) that Baillie Gifford, an investment firm that owns 9 perfect of Tesla ($TSLA), is acquiring around 11 percent of NIO.
The investment shows that we're still in the early stages of a match to own the exploding market for luxury electric vehicles, and deep-pocketed investors seem willing to back more than one horse at a time.
"We're in uncharted territory now," said Tamara Warren, co-host of Cheddar Rides.
But NIO isn't Tesla.
Despite its troubles, Elon Musk's company has a soup-to-nuts production component.
NIO, on the other hand, doesn't actually make its own vehicles, as Warren noted. Instead, it has an agreement with a Chinese manufacturer. So while NIO proclaims itself to be a Tesla rival, "no one knows who's going to give Tesla run for their money," Warren said.
NIO raised $1 billion in a public offering last month on the NYSE, though it stumbled out of the gate. After more than doubling in its first few days on the market, shares feel back below their IPO price. With Wednesday's gains, the stock is at its highest level since Sept. 25.
Meridith McGraw, White House Reporter at The Wall Street Journal, breaks down Trump’s $200M ballroom plan, D.C. police tensions, and the future of MAGA.
After years of being told that red wine was good for heart health, more Americans appear to be heeding warnings that even moderate alcohol consumption can be unhealthy.
Amazon is now rolling out a service where its Prime members can order their blueberries and milk at the same time as their batteries and other basic items.
Dr. Richard Besser, President & CEO of the Robert Wood Johnson Foundation and former CDC acting director, unpacks the impact of RFK's mRNA funding cuts.
Jessica Inskip, Director of Investor Research at StockBrokers.com and host of MarketMakeHer, unpacks earnings, market outlook, and what history says is next.
Laura Desmond, CEO of Smartly, explores how Big Tech giants are competing for ad dollars in a shifting digital landscape and how Smartly is here to help.
